196 related articles for article (PubMed ID: 9252984)
1. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.
Jentsch JD; Tran A; Le D; Youngren KD; Roth RH
Neuropsychopharmacology; 1997 Aug; 17(2):92-9. PubMed ID: 9252984
[TBL] [Abstract][Full Text] [Related]
2. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Jentsch JD; Taylor JR; Roth RH
Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
[TBL] [Abstract][Full Text] [Related]
3. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Jentsch JD; Redmond DE; Elsworth JD; Taylor JR; Youngren KD; Roth RH
Science; 1997 Aug; 277(5328):953-5. PubMed ID: 9252326
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
5. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
Balla A; Sershen H; Serra M; Koneru R; Javitt DC
Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
[TBL] [Abstract][Full Text] [Related]
6. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
7. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.
Jentsch JD; Dazzi L; Chhatwal JP; Verrico CD; Roth RH
Neurosci Lett; 1998 Dec; 258(3):175-8. PubMed ID: 9885959
[TBL] [Abstract][Full Text] [Related]
8. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
9. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.
Elsworth JD; Jentsch JD; Morrow BA; Redmond DE; Roth RH
Neuropsychopharmacology; 2008 Feb; 33(3):491-6. PubMed ID: 17507917
[TBL] [Abstract][Full Text] [Related]
10. Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats.
Young AM; Stubbendorff C; Valencia M; Gerdjikov TV
Neuroscience; 2015 Feb; 287():157-63. PubMed ID: 25542422
[TBL] [Abstract][Full Text] [Related]
11. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.
Jentsch JD; Tran A; Taylor JR; Roth RH
Psychopharmacology (Berl); 1998 Jul; 138(1):89-95. PubMed ID: 9694531
[TBL] [Abstract][Full Text] [Related]
12. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Jentsch JD; Wise A; Katz Z; Roth RH
Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014
[TBL] [Abstract][Full Text] [Related]
13. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
[TBL] [Abstract][Full Text] [Related]
14. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.
Adams B; Moghaddam B
J Neurosci; 1998 Jul; 18(14):5545-54. PubMed ID: 9651235
[TBL] [Abstract][Full Text] [Related]
15. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
[TBL] [Abstract][Full Text] [Related]
16. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization.
George TP; Verrico CD; Picciotto MR; Roth RH
J Pharmacol Exp Ther; 2000 Oct; 295(1):58-66. PubMed ID: 10991961
[TBL] [Abstract][Full Text] [Related]
18. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
Takahata R; Moghaddam B
Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
[TBL] [Abstract][Full Text] [Related]
19. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
[TBL] [Abstract][Full Text] [Related]
20. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]